These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15264742)

  • 21. Hyoscine-B butyl bromide in labor: a randomized controlled trial.
    Jacob R
    Indian J Med Sci; 2009 Aug; 63(8):364-5; author reply 365-6. PubMed ID: 19770529
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter to the Editor Re: "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later".
    Clark K; Sheehan C; Currow DC
    J Pain Symptom Manage; 2019 Jan; 57(1):e16-e17. PubMed ID: 30367928
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of intravenously administered hyoscine butyl bromide in retrograde terminal ileoscopy: a randomized, double-blinded, placebo-controlled trial.
    Misra SP; Dwivedi M
    World J Gastroenterol; 2007 Mar; 13(12):1820-3. PubMed ID: 17465473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures.
    Tytgat GN
    Curr Med Res Opin; 2008 Nov; 24(11):3159-73. PubMed ID: 18851775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medications influencing central cholinergic pathways affect fixation stability, saccadic response time and associated eye movement dynamics during a temporally-cued visual reaction time task.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Modenese L; Kavanagh JJ
    Psychopharmacology (Berl); 2017 Feb; 234(4):671-680. PubMed ID: 27988806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual side-effects from transdermal scopolamine (hyoscine).
    Firth AY; Walker K
    Dev Med Child Neurol; 2006 Feb; 48(2):137-8. PubMed ID: 16417670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Clissold SP; Heel RC
    Drugs; 1985 Mar; 29(3):189-207. PubMed ID: 3886352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care.
    Barcia E; Reyes R; Luz Azuara M; Sánchez Y; Negro S
    Support Care Cancer; 2003 Feb; 11(2):107-13. PubMed ID: 12560939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hyoscine N-butylbromide on gastroesophageal reflux in normal subjects and patients with gastroesophageal reflux disease.
    Ciccaglione AF; Grossi L; Cappello G; Malatesta MG; Ferri A; Toracchio S; Marzio L
    Am J Gastroenterol; 2001 Aug; 96(8):2306-11. PubMed ID: 11519531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction.
    Mercadante S
    J Pain Symptom Manage; 1998 Nov; 16(5):278-80. PubMed ID: 9846021
    [No Abstract]   [Full Text] [Related]  

  • 31. Medications influencing central cholinergic neurotransmission affect saccadic and smooth pursuit eye movements in healthy young adults.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Kavanagh JJ
    Psychopharmacology (Berl); 2017 Jan; 234(1):63-71. PubMed ID: 27671681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of hyoscine butylbromide in patients under general anaesthesia.
    Quintero C; Molano MF; Amaya S; Maya JJ; Andrade MJ
    J Perioper Pract; 2023; 33(7-8):211-216. PubMed ID: 35285310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticholinergic medications for managing noisy respirations in adult hospice patients.
    Kintzel PE; Chase SL; Thomas W; Vancamp DM; Clements EA
    Am J Health Syst Pharm; 2009 Mar; 66(5):458-64. PubMed ID: 19233993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of hyoscine N-butyl bromide (HBB, buscopan) as labor analgesic.
    Aggarwal P; Zutshi V; Batra S
    Indian J Med Sci; 2008 May; 62(5):179-84. PubMed ID: 18579976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of two oral hyoscine butylbromide formulations in Chinese patients with recurrent episodes of self-reported gastric or intestinal spasm-like pain.
    Ge Z; Yuan Y; Zhang S; Hou X; Wang J; Cai J; Shi R; Li Y; Wang B; Ji F; Richter E; Schaefer E
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):198-205. PubMed ID: 21329622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects.
    Furey ML; Zarate CA
    J Clin Psychiatry; 2013 Aug; 74(8):850-1. PubMed ID: 24021505
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyoscine butylbromide in labour.
    GARRETT AS; DRAPER VS
    Practitioner; 1963 May; 190():653-6. PubMed ID: 13960471
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute urticaria induced by hyoscine butylbromide.
    González-Mendiola R; Sánchez Fernández C; Prieto Montaño P; Cuevas M; Ceña Delgado M; Sánchez Cano M
    Allergy; 2004 Jul; 59(7):787-8. PubMed ID: 15180769
    [No Abstract]   [Full Text] [Related]  

  • 39. Oesophageal spasm, vomiting and hyoscine hydrobromide patch.
    Murray-Brown F; Davies IL
    BMJ Support Palliat Care; 2016 Mar; 6(1):125-7. PubMed ID: 26667134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scopolamine sublingual spray: an alternative route of delivery for the treatment of motion sickness.
    Al-Ghananeem AM; Malkawi AH; Crooks PA
    Drug Dev Ind Pharm; 2007 May; 33(5):577-82. PubMed ID: 17520450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.